Role of Caveolin-1 in the Maintenance of Blood-retinal Barrier Integrity
Caveolin-1 在维持血视网膜屏障完整性中的作用
基本信息
- 批准号:8963726
- 负责人:
- 金额:$ 36.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-12-01 至 2017-09-29
- 项目状态:已结题
- 来源:
- 关键词:AcuteAdverse effectsAge related macular degenerationAnimal ModelAnti-Inflammatory AgentsAnti-inflammatoryBioavailableBiological AvailabilityBlood VesselsBlood-Retinal BarrierCAV1 geneCaveolaeCellsComplexDiabetes MellitusDiabetic RetinopathyDiseaseEndotoxinsEnzymesExperimental Diabetes MellitusEye diseasesFlavonolsFundingGenesGlaucomaGoalsHomeostasisHyperactive behaviorImmuneImmune responseInflammationInflammatoryInflammatory ResponseInjuryIonsIsoflavonesKnockout MiceLinkMaintenanceMediatingMembrane MicrodomainsModelingNatural ImmunityNitric OxideOcular HypertensionOutcomePathologyPhysiologic Intraocular PressurePlayPositioning AttributePreclinical TestingPrimary Open Angle GlaucomaProductionPropertyProteinsRegulationReperfusion InjuryReportingRetinaRetinalRetinal DiseasesRiskRoleSignal TransductionSteroidsTestingTherapeuticTissuesTreatment EfficacyUveitisWorkacid sphingomyelinaseangiogenesisautoimmune uveitisbasecaveolin 1cytokinedaidzeinglycationhuman NOS3 proteinimprovedin vivoinhibitor/antagonistnew therapeutic targetnovelnovel therapeuticspathogenpre-clinicalpublic health relevanceresponse to injuryretinal damagetoll-like receptor 4tool
项目摘要
DESCRIPTION (provided by applicant): Caveolin-1 (Cav-1), the signature protein of caveolae membrane microdomains, is linked to several ocular/retinal diseases including primary open angle glaucoma, diabetic retinopathy, and autoimmune uveitis. We have found that Cav-1 and caveolae play important roles in blood-retinal barrier (BRB) integrity, retinal ion homeostasis, and retinal function. More recently, we have found that Cav-1 plays a prominent role in promoting retinal inflammatory signaling and inflammatory BRB breakdown. These results imply that local disruption of Cav-1 function presents a viable therapy to suppress retinal inflammatory insults. Given that current steroid- based therapies for retinal inflammatory disease are not completely effective and fraught with potentially severe side effects, we hypothesize that Cav-1 and caveolae domains represent novel therapeutic targets to suppress retinal inflammation. In order to effectively evaluate the therapeutic potential of suppressing Cav-1 function locally in th retina, it is imperative to understand the mechanisms for these complex cell-intrinsic properties. In this proposal we will use cell-specific Cav-1 knockout mice to test cell-intrinsic Cav-1 functions in the hope of validating Cav-1 as a new therapeutic target for retinal inflammation, BRB breakdown, and inflammatory angiogenesis. The specific aims of this proposal are: 1) to determine which Cav-1-expressing cells promote retinal inflammatory signaling and BRB breakdown, in vivo; 2) to test the mechanism by which Cav-1 modulates inflammatory signaling and BRB breakdown in two disease relevant models, endotoxin- induced uveitis and acute ocular hypertension and; 3) to test preclinical therapeutic strategies to locally disrupt Cav-1-dependent inflammatory signaling and BRB breakdown. These goals have clear
描述(由申请人提供):Caveolin-1 (Cav-1) 是小窝膜微结构域的标志蛋白,与多种眼部/视网膜疾病有关,包括原发性开角型青光眼、糖尿病性视网膜病变和自身免疫性葡萄膜炎。我们发现 Cav-1 和小窝在血视网膜屏障 (BRB) 完整性、视网膜离子稳态和视网膜功能中发挥重要作用。最近,我们发现 Cav-1 在促进视网膜炎症信号传导和炎症 BRB 分解中发挥着重要作用。这些结果表明,局部破坏 Cav-1 功能是抑制视网膜炎症损伤的可行疗法。鉴于目前基于类固醇的视网膜炎症疗法并不完全有效并且充满潜在的严重副作用,我们假设 Cav-1 和小凹结构域代表了抑制视网膜炎症的新治疗靶点。为了有效评估视网膜局部抑制 Cav-1 功能的治疗潜力,必须了解这些复杂的细胞固有特性的机制。在本提案中,我们将使用细胞特异性 Cav-1 敲除小鼠来测试细胞固有的 Cav-1 功能,希望验证 Cav-1 作为视网膜炎症、BRB 破坏和炎症血管生成的新治疗靶点。该提案的具体目标是:1)确定哪些表达 Cav-1 的细胞在体内促进视网膜炎症信号传导和 BRB 分解; 2)测试Cav-1在内毒素诱导的葡萄膜炎和急性高眼压这两种疾病相关模型中调节炎症信号传导和BRB分解的机制; 3) 测试局部破坏 Cav-1 依赖性炎症信号传导和 BRB 分解的临床前治疗策略。这些目标有明确的
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHAEL H ELLIOTT其他文献
MICHAEL H ELLIOTT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHAEL H ELLIOTT', 18)}}的其他基金
Caveolae-based mechanosensors for conventional outflow regulation
用于传统流出调节的基于小凹的机械传感器
- 批准号:
10186755 - 财政年份:2018
- 资助金额:
$ 36.78万 - 项目类别:
Caveolae-based mechanosensors for conventional outflow regulation
用于传统流出调节的基于小凹的机械传感器
- 批准号:
9596193 - 财政年份:2018
- 资助金额:
$ 36.78万 - 项目类别:
Role of Caveolin-1 in the Maintenance of Blood-retinal Barrier Integrity
Caveolin-1 在维持血视网膜屏障完整性中的作用
- 批准号:
10683155 - 财政年份:2009
- 资助金额:
$ 36.78万 - 项目类别:
Role of caveolin-1 in the maintenance of blood-retinal barrier integrity
Caveolin-1 在维持血视网膜屏障完整性中的作用
- 批准号:
9563983 - 财政年份:2009
- 资助金额:
$ 36.78万 - 项目类别:
Role of Caveolin-1 in the Maintenance of Blood-retinal Barrier Integrity
Caveolin-1 在维持血视网膜屏障完整性中的作用
- 批准号:
10475582 - 财政年份:2009
- 资助金额:
$ 36.78万 - 项目类别:
Role of Caveolin-1 in the Maintenance of Blood-retinal Barrier Integrity
Caveolin-1 在维持血视网膜屏障完整性中的作用
- 批准号:
8197255 - 财政年份:2009
- 资助金额:
$ 36.78万 - 项目类别:
Role of Caveolin-1 in the Maintenance of Blood-retinal Barrier Integrity
Caveolin-1 在维持血视网膜屏障完整性中的作用
- 批准号:
7783730 - 财政年份:2009
- 资助金额:
$ 36.78万 - 项目类别:
相似海外基金
Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
- 批准号:
10591918 - 财政年份:2023
- 资助金额:
$ 36.78万 - 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
- 批准号:
23K15383 - 财政年份:2023
- 资助金额:
$ 36.78万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
- 批准号:
23H03556 - 财政年份:2023
- 资助金额:
$ 36.78万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
- 批准号:
23K17212 - 财政年份:2023
- 资助金额:
$ 36.78万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
- 批准号:
22H03519 - 财政年份:2022
- 资助金额:
$ 36.78万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
- 批准号:
563657-2021 - 财政年份:2022
- 资助金额:
$ 36.78万 - 项目类别:
Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10521849 - 财政年份:2022
- 资助金额:
$ 36.78万 - 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10671022 - 财政年份:2022
- 资助金额:
$ 36.78万 - 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
- 批准号:
10670918 - 财政年份:2022
- 资助金额:
$ 36.78万 - 项目类别:
Downsides of downhill: The adverse effects of head vibration associated with downhill mountain biking on visuomotor and cognitive function
速降的缺点:与速降山地自行车相关的头部振动对视觉运动和认知功能的不利影响
- 批准号:
2706416 - 财政年份:2022
- 资助金额:
$ 36.78万 - 项目类别:
Studentship